• Explore /
  • Poster
  • / Phase 2 clinical trial of the proautophagic drug ABTL0812 combined with paclitaxel and carboplatin in first-line patients with advanced squamous non-small cell lung carcinoma.

Phase 2 clinical trial of the proautophagic drug ABTL0812 combined with paclitaxel and carboplatin in first-line patients with advanced squamous non-small cell lung carcinoma.

Abstract Poster

Authors

null

Joaquim Bosch-Barrera

Catalan Institute of Oncology, Hospital Josep Trueta, IDIBGi. Medical Oncology, Girona, Spain

Joaquim Bosch-Barrera , Teresa Moran , Purificación Estévez-García , Paloma Martín-Martorell , Renaud Sabatier , Ernest Nadal , Jose M. Lizcano , Oriol Pedrós-Gámez , Héctor Pérez-Montoyo , Marc Yeste-Velasco , Carles Domenech , Jose Alberto Alfon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT03366480

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 9059)

DOI

10.1200/JCO.2023.41.16_suppl.9059

Abstract #

9059

Poster Bd #

47

Abstract Disclosures

Similar Posters

First Author: Lorena Farinas-Madrid

First Author: Xiangrui Meng

First Author: Yuangyuan Zhao

First Author: Peter H. O'Donnell